Rating Rationale
January 06, 2021 | Mumbai
Arjuna Natural Private Limited
Ratings reaffirmed at 'CRISIL A / Stable / CRISIL A1 '; rated amount enhanced for Bank Debt
 
Rating Action
Total Bank Loan Facilities RatedRs.75 Crore (Enhanced from Rs.50 Crore)
Long Term RatingCRISIL A/Stable (Reaffirmed)
Short Term RatingCRISIL A1 (Reaffirmed)
1 crore = 10 million
Refer to Annexure for Details of Instruments & Bank Facilities

Detailed Rationale

CRISIL has reaffirmed its ratings on the bank facilities of Arjuna Natural Pvt Ltd (ANPL; a part of the Arjuna group) at 'CRISIL A/Stable/CRISIL A1'.

 

The ratings continue to reflect the Arjuna group's established position in the nutraceutical business, aided by the extensive experience of its promoter, and robust financial risk profile. These strengths are partially offset by product concentration risks, large working capital requirement and susceptibility to regulatory changes in the domestic and global markets.

Analytical Approach

For arriving at its ratings, CRISIL has combined the business and financial risk profiles of ANPL and its subsidiaries, Kingston Packings Pvt Ltd (KPPL) and Livlong Nutraceuticals Ltd (LNL), together referred to Arjuna group. This is because the entities are under the same management.

 

Please refer Annexure - Details of Consolidation, which captures the list of entities considered and their analytical treatment of consolidation.

Key Rating Drivers & Detailed Description

Strengths:

Strong market position and established presence in export markets

The Arjuna group benefits from its established market position in the nutraceuticals segment, supported by its promoters' extensive experience, strong research and development capabilities, and established product lines. The promoters, Mr P J Kunjachan and Mr Benny Antony, have been instrumental in successfully commercialising various herbal extracts and continuously developing products. The group's flagship product, BCM 95, maintains its stronghold as one of the leading bioavailable curcumin extracts in the market (bioavailability denotes the degree to which a drug is absorbed in a patient's body). The business risk profile will likely remain supported by its established market position in the nutraceutical segment and the extensive experience of the promoters.

 

Strong financial risk profile

The financial risk profile should remain supported by steady accretion to reserve and the absence of any large, debt-funded capital expenditure (capex). Networth and total outside liabilities to tangible networth (TOL/TNW) were healthy at Rs 241 crore and 0.19 time, respectively, as on March 31, 2020. Debt protection metrics were robust, with interest coverage and net cash accrual to total debt ratios of 22.80 times and 2.09 times, respectively, for fiscal 2020.

 

Weakness:

Product concentration risk and large working capital requirement

The Arjuna group has a diverse product profile of over 50 products. However, majority of its revenue is derived from only 3-4 products, which exposes it to risks related to product concentration. Operations are also working capital intensive; gross current assets were sizeable at 232 days as on March 31, 2020, driven by huge inventory of up to 100 days and debtors of about 70 days.  

 

Susceptibility to fluctuations in raw material availability and prices

Raw materials, being agricultural commodities, are subject to risks of availability owing to adverse climatic conditions and the resultant volatility in prices. This was seen during 2009 and 2010 when severe crop failure had resulted in input prices increasing sharply. While operating profitability should remain healthy over the medium term, any significant volatility in raw material prices and inability to pass on such price increases to end customers immediately could constrain operating profitability and cash accrual.

Liquidity: Strong

The Arjuna group has strong liquidity driven by healthy cash accrual, moderately utilised bank lines and adequate unencumbered cash & cash equivalents. Net cash accrual is projected at about Rs 55 crore per annum over the medium term, against minimal debt obligation of around Rs 4 crore; the surplus cash can aid financial flexibility. Due to healthy cash accrual generation, bank limit utilisation was low and averaged 40% during the 12 months through July 2020. Also, cash surplus (in the form of unencumbered fixed deposits and investments in mutual funds) was sizeable at Rs 114.5 crore as on September 23, 2020.

Outlook Stable

The Arjuna group financial risk profile should remain strong, supported by healthy cash accrual that will be sufficient to meet capex and incremental working capital requirement.

Rating Sensitivity factors

Upward factors

  • Strong growth in revenue by 25-30% per annum, while reducing product concentration risks, and steady operating margin
  • Higher-than-expected cash accrual and significant improvement in working capital cycle

 

Downward factors

  • Steep decline in revenue and profitability
  • Large, debt-funded capex or a further sizeable stretch in working capital cycle, resulting in the TOL/TNW ratio increasing to over 1 times

About the Group

ANPL (earlier known has Arjuna Natural Extracts Ltd), incorporated in 1992, is a Kochi (Kerala)-based company that manufactures herbal and other natural extracts; these extracts are used in the manufacture of food supplements. Mr P J Kunjachan and Mr Benny Antony are promoters.

 

KPPL, established in 1990, is a non-operating company.

 

LNL, incorporated in 2001, involve in encapsulates turmeric powder.

Key Financial Indicators

Particulars - consolidated

Unit

2020*

2019

Revenue

Rs crore

224

297

Profit after tax (PAT)

Rs crore

30

35

PAT margin

%

13.4

11.9

Adjusted debt/adjusted networth

Times

0.07

0.26

Interest coverage

Times

22.87

20.82

*Provisional

Status of non cooperation with previous CRA:

ANPL had not cooperated with Acuite Ratings and Research Ltd, which classified it as non-cooperative vide release dated July 1, 2020, April 15, 2020. The reason provided by Acuite Ratings and Research Ltd is non-furnishing of information by ANPL for monitoring of ratings.

Any other information: Not applicable

Note on complexity levels of the rated instrument:
CRISIL complexity levels are assigned to various types of financial instruments. The CRISIL complexity levels are available on www.crisil.com/complexity-levels. Users are advised to refer to the CRISIL complexity levels for instruments that they consider for investment. Users may also call the Customer Service Helpdesk with queries on specific instruments.

Annexure - Details of Instrument(s)

ISIN

Name of Instrument

Date of Allotment

Coupon Rate (%)

Maturity Date

Issue Size (Rs Crore)

Complexity Levels

Rating Assigned with Outlook

NA

Pre Shipment Finance

NA

NA

NA

40.0

NA

CRISIL A1

NA

Cash Credit

NA

NA

NA

0.8

NA

CRISIL A/Stable

NA

Working Capital Facility

NA

NA

NA

30.0

NA

CRISIL A/Stable

NA

Proposed Working Capital Facility

NA

NA

NA

4.20

NA

CRISIL A/Stable

 

Annexure – List of entities consolidated

Entity consolidated

Extent of consolidation

Rationale for consolidation

Liv Long Nutraceuticals Limited

Full

Subsidiary

Kingston Packings Pvt Ltd

Full

Subsidiary

 

Annexure - Rating History for last 3 Years
  Current 2020 (History) 2019  2018  Start of 2018
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Rating
Fund Based Facilities ST/LT 75.0 CRISIL A1 / CRISIL A/Stable 29-09-20 CRISIL A1 / CRISIL A/Stable   -- 04-01-18 Withdrawn CRISIL A2+ / CRISIL A-/Positive
Non-Fund Based Facilities ST   -- 29-09-20 CRISIL A1   -- 04-01-18 Withdrawn CRISIL A2+
All amounts are in Rs.Cr.
 
 
Annexure - Details of various bank facilities
Current facilities Previous facilities
Facility Amount (Rs.Crore) Rating Facility Amount (Rs.Crore) Rating
Cash Credit 0.8 CRISIL A/Stable Bank Guarantee 0.5 CRISIL A1
Pre Shipment Finance 40 CRISIL A1 Cash Credit 0.8 CRISIL A/Stable
Proposed Working Capital Facility 4.2 CRISIL A/Stable Letter of Credit 1.5 CRISIL A1
Working Capital Facility 30 CRISIL A/Stable Pre Shipment Credit 7 CRISIL A1
- - - Pre Shipment Finance 35 CRISIL A1
- - - Working Capital Facility 5.2 CRISIL A/Stable
Total 75 - Total 50 -
Links to related criteria
CRISILs Approach to Financial Ratios
Rating criteria for manufaturing and service sector companies
CRISILs Bank Loan Ratings - process, scale and default recognition
CRISILs Criteria for rating short term debt
CRISILs Criteria for Consolidation

Media Relations
Analytical Contacts
Customer Service Helpdesk
Saman Khan
Media Relations
CRISIL Limited
D: +91 22 3342 3895
B: +91 22 3342 3000
saman.khan@crisil.com

Naireen Ahmed
Media Relations
CRISIL Limited
D: +91 22 3342 1818
B: +91 22 3342 3000
 naireen.ahmed@crisil.com

Dinesh Jain
Director - CRISIL Ratings
CRISIL Limited
D:+91 44 6656 3115
Dinesh.Jain@crisil.com


Rajaraman Seetharaman
Associate Director - CRISIL Ratings
CRISIL Limited
D:+91 40 4032 8200
Rajaraman.Seetharaman@crisil.com


Suresh Gundaboyana
Senior Rating Analyst - CRISIL Ratings
CRISIL Limited
D:+91 22 3342 3419
Suresh.Gundaboyana@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper / magazine / agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL. However, CRISIL alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites, portals etc.


About CRISIL Limited

CRISIL is a global analytical company providing ratings, research, and risk and policy advisory services. We are India's leading ratings agency. We are also the foremost provider of high-end research to the world's largest banks and leading corporations.

CRISIL is majority owned by S&P Global Inc., a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide.

For more information, visit www.crisil.com 


Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK


About CRISIL Ratings
CRISIL Ratings is part of CRISIL Limited (“CRISIL”). We pioneered the concept of credit rating in India in 1987. CRISIL is registered in India as a credit rating agency with the Securities and Exchange Board of India (“SEBI”). With a tradition of independence, analytical rigour and innovation, CRISIL sets the standards in the credit rating business. We rate the entire range of debt instruments, such as, bank loans, certificates of deposit, commercial paper, non-convertible / convertible / partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 24,500 large and mid-scale corporates and financial institutions. CRISIL has also instituted several innovations in India in the rating business, including rating municipal bonds, partially guaranteed instruments and microfinance institutions. We also pioneered a globally unique rating service for Micro, Small and Medium Enterprises (MSMEs) and significantly extended the accessibility to rating services to a wider market. Over 95,000 MSMEs have been rated by us.



CRISIL PRIVACY NOTICE

CRISIL respects your privacy. We use your contact information, such as your name, address, and email id, to fulfil your request and service your account and to provide you with additional information from CRISIL and other parts of S&P Global Inc. and its subsidiaries (collectively, the “Company) you may find of interest.

For further information, or to let us know your preferences with respect to receiving marketing materials, please visit www.crisil.com/privacy. You can view the Company’s Customer Privacy at https://www.spglobal.com/privacy

Last updated: April 2016


DISCLAIMER

This disclaimer forms part of and applies to each credit rating report and/or credit rating rationale that we provide (each a “Report”). For the avoidance of doubt, the term “Report” includes the information, ratings and other content forming part of the Report. The Report is intended for the jurisdiction of India only. This Report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the Report is to be construed as CRISIL providing or intending to provide any services in jurisdictions where CRISIL does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this Report does not create a client relationship between CRISIL and the user.

We are not aware that any user intends to rely on the Report or of the manner in which a user intends to use the Report. In preparing our Report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the Report is not intended to and does not constitute an investment advice. The Report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind or otherwise enter into any deal or transaction with the entity to which the Report pertains. The Report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Rating are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold, or sell any securities / instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL assumes no obligation to update its opinions following publication in any form or format although CRISIL may disseminate its opinions and analysis. CRISIL rating contained in the Report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the Report should rely on their own judgment and take their own professional advice before acting on the Report in any way.

Neither CRISIL nor its affiliates, third party providers, as well as their directors, officers, shareholders, employees or agents (collectively, “CRISIL Parties”) guarantee the accuracy, completeness or adequacy of the Report, and no CRISIL Party shall have any liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the Report. EACH CRISIL PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the Report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. CRISIL’s public ratings and analysis as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any) are made available on its web sites, www.crisil.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee – more details about CRISIL ratings are available here: www.crisilratings.com.

CRISIL and its affiliates do not act as a fiduciary. While CRISIL has obtained information from sources it believes to be reliable, CRISIL does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and / or relies in its Reports. CRISIL keeps certain activities of its business units separate from each other in order to preserve the independence and objectivity of the respective activity. As a result, certain business units of CRISIL may have information that is not available to other CRISIL business units. CRISIL has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL has in place a ratings code of conduct and policies for analytical firewalls and for managing conflict of interest. For details please refer to: http://www.crisil.com/ratings/highlightedpolicy.html

CRISIL’s rating criteria are generally available without charge to the public on the CRISIL public web site, www.crisil.com. For latest rating information on any instrument of any company rated by CRISIL you may contact CRISIL RATING DESK at CRISILratingdesk@crisil.com, or at (0091) 1800 267 1301.

This Report should not be reproduced or redistributed to any other person or in any form without a prior written consent of CRISIL.

All rights reserved @ CRISIL

CRISIL uses the prefix ‘PP-MLD’ for the ratings of principal-protected market-linked debentures (PPMLD) with effect from November 1, 2011 to comply with the SEBI circular, "Guidelines for Issue and Listing of Structured Products/Market Linked Debentures". The revision in rating symbols for PPMLDs should not be construed as a change in the rating of the subject instrument. For details on CRISIL's use of 'PP-MLD' please refer to the notes to Rating scale for Debt Instruments and Structured Finance Instruments at the following link: www.crisil.com/ratings/credit-rating-scale.html